0001680048-17-000003.txt : 20170215 0001680048-17-000003.hdr.sgml : 20170215 20170215140618 ACCESSION NUMBER: 0001680048-17-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170215 DATE AS OF CHANGE: 20170215 EFFECTIVENESS DATE: 20170215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MUSTANG BIO, INC. CENTRAL INDEX KEY: 0001680048 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473828760 STATE OF INCORPORATION: DE FISCAL YEAR END: 0312 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-272604 FILM NUMBER: 17614058 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 7816524507 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 D/A 1 primary_doc.xml X0707 D/A LIVE 0001680048 MUSTANG BIO, INC. 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY NEW YORK 10014 7816524507 DELAWARE Mustang Therapeutics, Inc. None Corporation true 2015 Michael S. Weiss c/o 2 Gansevoort Street 9th Floor New York NY NEW YORK 10014 Executive Officer Director Lindsay A. Rosenwald c/o 2 Gansevoort Street 9th Floor New York NY NEW YORK 10014 Director Neil Herskowitz c/o 2 Gansevoort Street 9th Floor New York NY NEW YORK 10014 Director Biotechnology Decline to Disclose 06b true 0001680048-17-000002 2017-01-31 false true true false 0 National Securities Corporation 7569 National Securities Corporation 7569 410 Park Avenue 14th Floor New York NY NEW YORK 10022 All States false 100000000 94585711 5414289 false 1086 9478571 0 0 Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering. false MUSTANG BIO, INC. /s/ Michael S. Weiss Michael S. Weiss President and Chief Executive Officer 2017-02-15